Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuron-neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase

Journal of Neuroscience Research
Jung-Soo PyoByung Lan Lee

Abstract

Mutations in the superoxide dismutase 1 (SOD1) gene are linked to glutamate excitotoxicity in familial amyotrophic lateral sclerosis (fALS), but the underlying mechanism remains unclear. We investigated whether nuclear factor-kappaB (NF-kappaB) activation is involved in glutamate excitotoxicity by using motor neuron-neuroblastoma hybrid cells that expressed a mutant (G93A) SOD1 (mtSOD1) or wild-type SOD1 (wtSOD1). MtSOD1 cells were more vulnerable to glutamate excitotoxicity than wtSOD1 cells and showed higher NF-kappaB activity, higher nuclear cRel expression, and lower nuclear RelA expression under basal conditions. Glutamate treatment increased NF-kappaB activation along with nuclear expressions of RelA and cRel in wtSOD1 cells but induced only weak nuclear RelA expression in mtSOD1 cells. Suppression of NF-kappaB activation using transfection of the superrepressive mutant form of IkappaBalpha (mIkappaBalpha) inhibited nuclear RelA expression in both types of SOD1 cells, which increased glutamate excitotoxicity in wtSOD1 cells but not in mtSOD1 cells. Furthermore, immunohistochemistry confirmed stronger RelA immunoreactivity in the nuclei of motor neurons of spinal cord in wild-type SOD1 transgenic mice than in those in SOD1...Continue Reading

References

May 1, 1997·Journal of Neurology·M E Gurney
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·S HunotE C Hirsch
Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·David S HowlandJeffrey D Rothstein
Jun 4, 2002·Nature Reviews. Molecular Cell Biology·Guy S Salvesen, Colin S Duckett
Oct 24, 2002·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Kwang-Woo LeeManho Kim
Nov 20, 2002·Journal of Neurochemistry·Arianna CasciatiMaria Teresa Carrì
May 18, 2004·Trends in Immunology·Giuseppina Bonizzi, Michael Karin
Oct 13, 2004·American Journal of Human Genetics·Catherine B Kunst
Jan 18, 2005·Trends in Biochemical Sciences·Patrick ViatourAlain Chariot
Jun 13, 2006·The International Journal of Biochemistry & Cell Biology·Vinay Tergaonkar
Jul 21, 2006·European Journal of Pharmacology·Marina Pizzi, Pierfranco Spano
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jennifer HarrisNathalie Grandvaux
Sep 26, 2006·Biochemical Pharmacology·Sylvie Mémet
Jul 6, 2007·BioFactors·Chae Hyeong LeeYong-Sang Song
Oct 7, 2008·Investigative Ophthalmology & Visual Science·Wei Fan, Nigel G F Cooper

❮ Previous
Next ❯

Citations

May 7, 2021·Computational and Mathematical Methods in Medicine·Dingsheng LiuXuefeng Gu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis